Abstract:OBJECTIVE:To evaluate the feasibility of in vivo magnetic resonance imaging (MRI) with 1.5T system tracking of the survival, migration and differentiation of magnetically labeled seed cells-bone marrow-derived mesenchymal stem cells (MSCs) injected into the articular cavity.METHODS:Rabbit MSCs were isolated, purified, expanded, and then coincubated in vitro with supermagnetic iron oxide particles (SPIO) and 5-bromo-2-deoxyuridine (BrdU). Prussian blue staining and transmission electron microscopy were performed to observe the intracellular iron. Some labeled MSCs were subjected to chondrogenic differentiation and the phenotype was examined to assess their chondrogenic differentiation capacity. MSCs colabeled with SPIO nanoparticles and (BrdU were suspended in chitosan and glycerophosphate (C-GP) gel. Eighteen rabbits underwent damage to the femoral trochlea to create cartilage defect models, and randomly divided into 3 groups 1 week later: Group A (n=6) undergoing injection of the MSC suspension in C-GP gel into the intra-articular space of knee joints, Group B (n=6), injected with un-labeled MSC suspension in C-GP gel, and Group C (n=6), without injection. MRI of the knee was performed 1, 4, 8, and 12 weeks after the injection respectively on a certain numbers of rabbits. and then the rabbits were killed with their knee joints taken out to undergo immunohistochemistry. The MR imaging findings were compared with the histological findings.RESULTS:Prussian blue staining and transmission electron microscopy showed intracytoplasmic nanoparticles in the SPIO-labeled cells. Safranin-O staining showed deposition of proteoglycan and type II collagen outside both the labeled and unlabeled MSCs, showing chondrogenesis. GRE T2-weighted MR image showed marked hypointense signal void areas, representing the implanted MSCs, in the intra-articular space after the MSC injection in Group A that persisted for 12 weeks at least; 2 week after the MSC injection hypointense signal could be seen in the defect, which peaked in the signal intensity about 4 weeks later, and then gradually decreased in the signal intensity; and 12 weeks after the injection no recognizable hypointense signal in the defect was detected. Immunohistochemical staining demonstrated the presence of Prussian blue-positive cells and BrdU-positive cells in the tissue sections in the areas corresponding well to the signal intensity loss regions in the MRI images. Group B and Group C showed no signal intensity loss in the intra-articular spaces by GRE T2-weighted MR imaging. Histological observation showed that the defects were repaired with fibrocartilage in Groups A and B, and with fiber tissue in Group C.CONCLUSION:Labeled with SPIO, the MSCs remains their ability of chondrogenic differentiation. It is feasible to track the fate and dynamic redistribution of magnetically labeled MSCs, the seed cells, injected into the articular cavity by 1.5T MRI, an efficient noninvasive technique.

In Vivo MR Imaging Tracking of Transplanted Mesenchymal Stem Cells in a Rabbit Model of Acute Peripheral Nerve Traction Injury.

MR Imaging of Implanted Magnetically Labeled Rat Bone Marrow Mesenchymal Stem Cells in Normal Kidney

In vivo MRI monitoring nerve regeneration of acute peripheral nerve traction injury following mesenchymal stem cell transplantation.

Evaluation of Cell Tracking Effects for Transplanted Mesenchymal Stem Cells with Jetpei/gd-Dtpa Complexes in Animal Models of Hemorrhagic Spinal Cord Injury.

Transplanted neural stem cells promote nerve regeneration in acute peripheral nerve traction injury: assessment using MRI.

Tracking of mesenchymal stem cells labeled with Gd-DTPA by MR imaging in spinal cord injury model

Magnetic resonance imaging of mesenchymal stem cells labeled with dual (MR and fluorescence) agents in rat spinal cord injury.

In vivo magnetic resonance imaging of iron oxide-labeled, intravenous-injected mesenchymal stem cells in kidneys of rabbits with acute ischemic kidney injury: detection and monitoring at 1.5 T

In Vivo Mri Tracking of Iron Oxide Nanoparticle-Labeled Human Mesenchymal Stem Cells in Limb Ischemia

Magnetic resonance imaging tracking and assessing repair function of the bone marrow mesenchymal stem cells transplantation in a rat model of spinal cord injury.

In Vivo MR Imaging Tracking of Magnetic Iron Oxide Nanoparticle Labeled, Engineered, Autologous Bone Marrow Mesenchymal Stem Cells Following Intra-Articular Injection.

Mri of Auto-Transplantation of Bone Marrow-Derived Stem-Progenitor Cells for Potential Repair of Injured Arteries

Identification and Differentiation of Magnetically Labeled Mesenchymal Stem Cells in Vivo in Swines with Myocardial Infarction.

Tracing Mesenchymal Stem Cells In Treated Uterine Horns Trauma Of Rats With Magnetic Resonance Imaging

In Vivo Tracking of the Tropism of Mesenchymal Stem Cells to Malignant Gliomas Using Reporter Gene-Based MR Imaging

Magnetic resonance imaging tracing of superparamagnetic iron oxide nanoparticle-labeled mesenchymal stromal cells for repairing spinal cord injury

Magnetic resonance imaging monitoring dual-labeled stem cells for treatment of mouse nerve injury

[In Vivo MR Imaging Tracking of Supermagnetic Iron-Oxide Nanoparticle-Labeled Bone Marrow Mesenchymal Stem Cells Injected into Intra-Articular Space of Knee Joints: Experiment with Rabbit].

Radionuclide imaging of mesenchymal stem cells transplanted into spinal cord.

In vivo MR tracking of subarachnoid space grafted magnetically labeled mesenchymal stem cells in rat spinal cord injury models

Study on MR Tracking of Magnetically Labeled Swine Mesenchymal Stem Cells after Autologous Transplantation into Acute Injured Liver in Vivo